PYMNTS.com October 16, 2024

Google DeepMind has developed an AI model to predict key properties of potential drugs, aiming to accelerate pharmaceutical research.

The new Tx-LLM (Therapeutic Large Language Model) model exemplifies a shift toward specialized artificial intelligence tools for specific industries. This targeted approach could prove more valuable than general-purpose AI in addressing complex commercial challenges.

“Industry-specific AI models are fundamentally reshaping business operations by leveraging the nuances of individual industries,” Adnan Masood, chief AI architect at UST, told PYMNTS.

Tx-LLM is an example of AI model fine-tuning, which involves taking a pre-trained model and refining it on a specific task or dataset to improve its performance in that area. This process allows the model to adapt to specialized needs without being built...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Pharma, Pharma / Biotech, Technology
Generative AI Is Helping To Clear Up Brain Fog
Getting started with AI agents (part 1): Capturing processes, roles and connections
Unlocking The Genetic Code: AI Reveals New Insights Into Psychiatric Disorders
5 questions for the Abundance Institute's Neil Chilson
AI agents are unlike any technology ever

Share This Article